More options are good news for patients, and the expansion of this drug class will make it easier for individuals to optimize their type 2 diabetes management
Contraindications for GLP-1 Medications GLP-1 medications may be contraindicated in people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take these medications
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormonal pathways involved in appetite regulation and blood sugar control
Compare this to 11.8% with cagrilintide alone and 16.1% with semaglutide alone
Retrieved July 29, 2025 from www.sciencedaily.com/releases/2025/07/250715043349.htm
News Release February 08, 2005 ConsumerLab.com reports on nutrition bars Highlights major differences, inaccuracies, and urges consumers to "know your bar" WHITE PLAINS, NY February 8, 2005 ConsumerLab.com reported test results today for 34 nutrition bars, including those designed for high protein, low-carb/diet, energy, or meal-replacement